A rare potentially fatal infection of the perineum, fournier gangrene, is associated with sodium-glucose cotransporter-2 (SGLT-2) inhibitors. Dr. Bersoff-Matcha published a review of 55 cases reported to FDA Adverse Event Reporting System through January 2019. A SGLT-2 inhibitor class label warning for fournier gangrene has been in place since mid 2018. To learn about this review, please click below.
Please share your thoughts and subscribe to receive my blogs.
Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram ReecesPiecesDI.